<DOC>
	<DOCNO>NCT00501267</DOCNO>
	<brief_summary>The purpose study determine effect repeat dose solabegron oxybutynin take alone together</brief_summary>
	<brief_title>A Study To Test The Interaction Two Medications Treatment Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Solabegron</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Healthy adult male &amp; female age 1865 ; Body weight &gt; 50kg ; BMI 1932 ; Signed date informed consent ; QTc Interval &lt; 450 msec ; Resting blood pressure &gt; 140/90 mmHg HR &gt; 100 screening ; History drug allergy allergy , opinion PI , contraindicate participation ; Positive urine drug , alcohol serum pregnancy test screen prior dosing ; Positive HIV , Hepatitis B , C screening ; use medication ( except acetaminophen ) vitamins herbal supplement within 7 day 5 half life prior dose study ; history urinary retention , gastric retention , sever gastrointestinal motility condition , uncontrolled narrowangle glaucoma risk condition ; history chronic constipation and/or regular laxative use ; donation 500mL blood within 56 day prior dose ; clinically relevant abnormality identify screen process medical condition circumstance make subject unsuitable participation base Investigators assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>solabegron ,</keyword>
	<keyword>oxybutynin ,</keyword>
	<keyword>healthy adult ,</keyword>
	<keyword>drug interaction</keyword>
</DOC>